13D/13G Filings - Athyrium Opportunities III Co-Invest 1 LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-09
5:40 pm
Purchase
2024-10-0713DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities III Co-Invest 1 LP2,574,453
49.900%
30,716increase
(+1.21%)
Filing
History
2024-09-13
10:37 am
Unchanged
2024-09-1013DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities III Co-Invest 1 LP2,543,737
49.900%
0
(Unchanged)
Filing
History
2024-08-14
9:58 pm
Purchase
2024-08-1213DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities III Co-Invest 1 LP2,543,737
49.900%
58,291increase
(+2.35%)
Filing
History
2024-07-08
9:42 pm
Purchase
2024-07-0313DBiora Therapeutics, Inc.
BIOR
Athyrium Opportunities III Co-Invest 1 LP2,485,446
49.900%
2,485,446increase
(New Position)
Filing
History